Europe — EMA

Ondansetron Kalceks

Ondansetron, the active ingredient in Ondansetron Kalceks, is a 5-HT3 receptor antagonist presented as a unknown/unknown for intramuscular, intravenous use.

Ondansetron

Request sourcing

Pack/s

What is Ondansetron?

Ondansetron, the active ingredient in Ondansetron Kalceks, is a 5-HT3 receptor antagonist presented as a unknown/unknown for intramuscular, intravenous use. It prevents nausea and vomiting associated with chemotherapy, radiotherapy and postoperative settings in patients undergoing these treatments.

GNH USA supplies Ondansetron Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

What is Ondansetron used for?

Ondansetron Kalceks acts on the serotonin pathway to prevent chemotherapy induced nausea and vomiting: - Chemotherapy‑induced nausea and vomiting: The ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... - Radiotherapy induced ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... - Post‑operative ... ... ... ... ... ... ... ... ... ... ... ... ... …

What are the side effects of Ondansetron?

Common ... ...

What precautions apply to Ondansetron?

...

What does Ondansetron interact with?

Major ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →